brand logo
  1. In men ages 55 to 69 years, in deciding whether to perform periodic prostate-specific antigen-based screening for prostate cancer, discuss potential benefits and harms of screening and incorporate patient values and preferences in the decision (ie, shared decision-making). Do not screen men who do not express a preference for screening.

  2. Do not perform digital rectal examination for prostate cancer screening.

  3. Consider prescribing an alpha1-adrenergic blocker (ie, alfuzosin, doxazosin, tamsulosin, terazosin) for men with benign prostatic hyperplasia (BPH) and bothersome, moderate to severe lower urinary tract symptoms (LUTS) due to BPH.

  4. Consider prescribing a 5-alpha reductase inhibitor for men with LUTS secondary to BPH with an enlarged prostate.

  5. Do not screen adolescent or adult males for testicular cancer.

  6. Consider prescribing a phosphodiesterase type 5 inhibitor as a first-line pharmacotherapy for men with erectile dysfunction.

Resources

  1. Strength of Evidence: SORT C

    Source: U.S. Preventive Services Task Force, reference 10

  2. Website: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening

  3. Strength of Evidence: SORT C

    Source: U.S. Preventive Services Task Force, reference 10

  4. Website: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening

  5. Strength of Evidence: SORT A

    Source: American Urological Association, reference 51

  6. Website: https://www.auajournals.org/doi/10.1016/j.juro.2011.01.074

  7. Strength of Evidence: SORT A

    Source: American Urological Association, reference 51

  8. Website: https://www.auajournals.org/doi/10.1016/j.juro.2011.01.074

  9. Strength of Evidence: SORT C

    Source: U.S. Preventive Services Task Force, reference 110

  10. Website: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/testicular-cancer-screening

  11. Strength of Evidence: SORT A

    Source: J Sex Med, reference 152

  12. Website: https://www.jsm.jsexmed.org/article/S1743-6095(16)00114-4/fulltext

Already a subscriber?  Log In

Subscribe

From $335
  • Immediate, unlimited access to all FP Essentials content
  • 60 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Edition Access

$59
  • Immediate, unlimited access to this edition's content
  • 5 CME credits
  • AAFP app access
  • Print delivery available
Interested in AAFP membership? Learn more  Learn More

Continue Reading

Copyright © 2021 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.